Randomized, Double-Blind, Controlled Study of Losartan in Children with Proteinuria

Abstract

Losartan significantly lowered proteinuria and was well tolerated after 12 weeks in children aged 1 to 17 years with proteinuria with or without hypertension, a population that has not previously been rigorously studied.